Page last updated: 2024-08-22

isopentenyladenosine and Leukemia

isopentenyladenosine has been researched along with Leukemia in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19902 (66.67)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Akimoto, M; Honma, Y; Ishii, Y; Ishikura, H; Kiyota, H; Tsumura, H1
Agris, PF; Burns, DM; Rodi, CP1
Chheda, GB; Evans, JT; Mittelman, A1

Other Studies

3 other study(ies) available for isopentenyladenosine and Leukemia

ArticleYear
Gene expression profiles in differentiating leukemia cells induced by methyl jasmonate are similar to those of cytokinins and methyl jasmonate analogs induce the differentiation of human leukemia cells in primary culture.
    Leukemia, 2009, Volume: 23, Issue:4

    Topics: Acetates; Cell Differentiation; Cyclopentanes; Cytokinins; Esters; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Hematologic Neoplasms; HL-60 Cells; Humans; Isopentenyladenosine; Leukemia; Oxylipins; Tumor Cells, Cultured

2009
Natural occurrence of an inhibitor of mammalian cell growth in human and mouse cells of normal and tumor origin.
    Cancer biochemistry biophysics, 1976, Volume: 1, Issue:6

    Topics: Adenosine; Animals; Cell Line; Cytoplasm; DNA, Neoplasm; Humans; Isopentenyladenosine; Leukemia; Mice; Neoplasm Proteins; RNA, Neoplasm; RNA, Transfer

1976
Cytokinins as chemotherapeutic agents.
    Annals of the New York Academy of Sciences, 1975, Aug-08, Volume: 255

    Topics: Adenosine; Cytokinins; Drug Evaluation; Humans; Isopentenyladenosine; Leukemia; Multiple Myeloma; Plant Growth Regulators

1975